Vane blood-bathed technique reveals the significance of adrenergic reaction in myocardial infarction

Pharmacological Reports

Volumn 62, Issue 3, 2010, Pages 457-461

  Herbaczyńska Cedro, Krystyna ^a   Ceremuźyński, Leszek ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b GROCHOWSKI HOSPITAL   (Poland)

Author keywords

Adrenaline; Aldosterone; Catecholamines; Myocardial infarction

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADRENALIN; ALDOSTERONE; HEXOKINASE; SUCCINATE DEHYDROGENASE; ADRENERGIC RECEPTOR; CATECHOLAMINE;

ADRENALIN RELEASE; ADRENERGIC ACTIVITY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BATHED TECHNIQUE; CLINICAL RESEARCH; CONTROLLED STUDY; DISEASE COURSE; DOG; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART INFARCTION; NONHUMAN; PLASMA RENIN ACTIVITY; REVIEW; ADRENERGIC SYSTEM; ANIMAL; BLOOD; HEART; HEART MUSCLE; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE ISCHEMIA; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; RAT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CATECHOLAMINES; DOGS; EPINEPHRINE; HEART; HEART CONDUCTION SYSTEM; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RATS; RECEPTORS, ADRENERGIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 77954859606     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70300-5     Document Type: Review

References (14)

1. Aleksandrow D, Januszewicz W, Wocial B: Urinary excretion of noradreanline, adrenaline and vanillylmigdalic acid in myocardial infarction (Polish). Pol Arch Med Wewn, 1966, 36, 437-442.
2. Ceremużyński L, Budaj A, Michorowski B: Single dose i.v. Aldactone for congestive heart failure: a preliminary observation. Int J Clin Pharmacol Ther Toxicol, 1983, 21, 417-421.
3. Ceremużyński L, Herbaczyńska-Cedro K, Broniszewska- Ardelt B, Nauman J, Nauman A, Wońniewicz B, Ławecki J: Evidence for detrimental effect of adrenaline infused to healthy dogs in doses imitating spontaneous secretion after coronary occlusion. Cardiovasc Res, 1978, 12, 179-189.
4. Ceremużyński L, Herbaczyńska-Cedro K, Wońniewicz B: Effectiveness of Insulin - Glucose in preventing adrenaline-induced myocardial and systemic distur- bances in the dog. Jap Circ J, 1980, 44, 740-478.
5. Ceremużyński L, Staszewska-Barczak J, Herbaczyńska- Cedro K: Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res, 1969, 3, 190-197.
6. Herbaczyńska-Cedro K: The influence of adrenaline secretion on the enzymes in heart muscle after acute coronary occlusion in dogs. Cardiovasc Res, 1970, 4, 168-175.
7. Herbaczyńska-Cedro K, Ceremużyński L, Broniszewska- Ardelt B: Beneficial effect of practolol in preventing adrenaline-induced systemic and myocardial metabolic changes. Eur J Clin Invest, 1979, 9, 309-315.
8. Herbaczyńska-Cedro K, Wońniewicz B, Broniszewska- Ardelt B, Ceremużyński L, Prevention of adrenaline- induced metabolic systemic and mycardial alterations by the)3-blocking agent metipranolol in the dog. Cardiology, 1981,67,206-218.
9. ISIS - 1 Collaborative Group: Randomized trial of intravenous Atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS - 1. Lancet, 1986, ii, 57-66.
10. Michorowski B, Ceremużyński L: The renin - angiotensin aldosterone system and the clinical course of acute myocardial infarction. Eur Heart J, 1983, 4, 259-264.
11. Raab W, Gigee W: Total urinary catechol excretion in cardiovascular and other clinical conditions. Circualtion, 1954, 9, 592-599.
12. Staszewska-Barczak J, Ceremużyński L: The continuous estimation of catecholamine release in the early stages of myocardial infarction in the dog. Clin Sci, 1968,34,531-539.
13. Valori C, Thomas M, Shillingford JP: Urinary excretion of free noradrenaline and adrenaline following myocardial infarction. Lancet, 1967, 1, 127-130.
14. Vane JR: The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol, 1964,23,360-373.